Cargando…

HER-2 overexpression is a negative predictive factor for recurrence in patients with non-muscle-invasive bladder cancer on intravesical therapy

OBJECTIVE: HER-2 is overexpressed in a variety of human malignant tumors and has been widely used in the prognosis and treatment of breast cancer. In urothelial cell carcinoma of the bladder, some reports have shown an association between HER-2 overexpression and worse outcomes. The aim of this stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moustakas, Georgios, Kampantais, Spyridon, Nikolaidou, Anastasia, Vakalopoulos, Ioannis, Tzioufa, Valentini, Dimitriadis, Georgios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Retrospective Clinical Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112244/ https://www.ncbi.nlm.nih.gov/pubmed/31937176 http://dx.doi.org/10.1177/0300060519895847

Ejemplares similares

mRNA overexpression of prolyl hydroxylase PHD3 is inversely related to nuclear grade in renal cell carcinoma
por: Kampantais, Spyridon, et al.
Publicado: (2020)

Comparison Between Ambulatory and Conventional Urodynamics of the Modified Orthotopic Hautmann Neobladder
por: Apostolos, Malioris, et al.
Publicado: (2015)

Should we expand the indications for varicocele treatment?
por: Vakalopoulos, Ioannis, et al.
Publicado: (2017)

Hypoxia-Inducible Factor 2a Expression Is Positively Correlated With Gleason Score in Prostate Cancer
por: Pavlakis, Dimitrios, et al.
Publicado: (2021)

Treatment of obstructive uropathy in one of three young brothers suffering from Gorlin-Cohen syndrome: a case report
por: Vakalopoulos, Ioannis, et al.
Publicado: (2012)

Urinothorax—An Underdiagnosed Cause of Acute Dyspnea: Report of a Bilateral and of an Ipsilateral Urinothorax Case
por: Laskaridis, Leonidas, et al.
Publicado: (2012)

New Artificial Urinary Sphincter Devices in the Treatment of Male Iatrogenic Incontinence
por: Vakalopoulos, Ioannis, et al.
Publicado: (2012)

Recurrence of choledocholithiasis following endoscopic bile duct clearance: Long term results and factors associated with recurrent bile duct stones
por: Konstantakis, Christos, et al.
Publicado: (2017)

Urethral Hairballs as a Long-Term Complication of Hypospadias Repair: Two Case Reports
por: Kampantais, Spyridon, et al.
Publicado: (2012)

Jackstone: A Calculus “Toy” in the Bladder. A Case Report of Rare Entity and Comprehensive Review of the Literature
por: Symeonidis, Evangelos N., et al.
Publicado: (2022)

Ureteral Guidewire Looping and Entrapment above an Impacted Ureter Stone
por: Tsionga, Aikaterini, et al.
Publicado: (2019)

Efficacy of Bladder Intravesical Chemotherapy with Three Drugs for Preventing Non-Muscle-Invasive Bladder Cancer Recurrence
por: Zhang, Jianglei, et al.
Publicado: (2021)

Predictive Markers for the Recurrence of Nonmuscle Invasive Bladder Cancer Treated with Intravesical Therapy
por: Miyata, Yasuyoshi, et al.
Publicado: (2015)

Intravesical chemotherapy in non-muscle-invasive bladder cancer
por: Porten, Sima P., et al.
Publicado: (2015)

HER2 heterogeneity is a poor prognosticator for HER2-positive gastric cancer
por: Kaito, Akio, et al.
Publicado: (2019)

Significance of HER2 protein expression and HER2 gene amplification in colorectal adenocarcinomas
por: Wang, Xin-Yu, et al.
Publicado: (2019)

Intravesical Treatments of Bladder Cancer: Review
por: Shen, Zancong, et al.
Publicado: (2008)

Intravesical therapy for urothelial carcinoma of the bladder
por: Manoharan, M.
Publicado: (2011)

Change point analysis validation of the learning curve in laparoscopic colorectal surgery: Experience from a non-structured training setting
por: Perivoliotis, Konstantinos, et al.
Publicado: (2022)

Squamous Cell Papilloma of the Urinary Bladder Endoscopically Mimicking Cancer
por: Miliaras, Dimosthenis, et al.
Publicado: (2013)

Phase I trial of intravesical Suramin in recurrent superficial transitional cell bladder carcinoma
por: Ord, J J, et al.
Publicado: (2005)

TERT C228T mutation in non‐malignant bladder urothelium is associated with intravesical recurrence for patients with non‐muscle invasive bladder cancer
por: Hayashi, Yujiro, et al.
Publicado: (2020)

PemBla: A Phase 1 study of intravesical pembrolizumab in recurrent non‐muscle‐invasive bladder cancer
por: Woodcock, Victoria K., et al.
Publicado: (2023)

Hyperthermia as Adjunct to Intravesical Chemotherapy for Bladder Cancer
por: Owusu, Richmond A., et al.
Publicado: (2013)

Intravesical immunotherapy in nonmuscle invasive bladder cancer
por: Jokisch, Jan-Friedrich, et al.
Publicado: (2015)

The use of intravesical BCG in urothelial carcinoma of the bladder
por: Alhunaidi, Omar, et al.
Publicado: (2019)

Intravesical Agents in the Treatment of Bladder Clots in Children
por: Della Corte, Marcello, et al.
Publicado: (2023)

Intravesical drug delivery approaches for improved therapy of urinary bladder diseases
por: Palugan, Luca, et al.
Publicado: (2021)

Recurrent urinary tract infections in patients with incomplete bladder emptying: is there a role for intravesical therapy?
por: Dray, Elizabeth V., et al.
Publicado: (2017)

Outcomes of seromuscular bladder augmentation compared with standard bladder augmentation in the treatment of children with neurogenic bladder
por: Sun, Xiao-Gang, et al.
Publicado: (2022)

Transforming urinary stone disease management by artificial intelligence-based methods: A comprehensive review
por: Anastasiadis, Anastasios, et al.
Publicado: (2023)

HER2/neu overexpression in the development of muscle-invasive transitional cell carcinoma of the bladder
por: Latif, Z, et al.
Publicado: (2003)

The Future of Intravesical Drug Delivery for Non-Muscle Invasive Bladder Cancer
por: Douglass, Laura, et al.
Publicado: (2016)

Device-assisted intravesical therapy for non-muscle invasive bladder cancer
por: Hendricksen, Kees
Publicado: (2019)

Thermal Intravesical Chemotherapy Reduce Recurrence Rate for Non-muscle Invasive Bladder Cancer Patients: A Meta-Analysis
por: Liu, Kang, et al.
Publicado: (2020)

Intravesical Gemcitabine versus Intravesical Bacillus Calmette–Guérin for the Treatment of Non-Muscle Invasive Bladder Cancer: An Evaluation of Efficacy and Toxicity
por: Prasanna, Thiru, et al.
Publicado: (2017)

Factors effecting recurrence and progression of high grade non invasive bladder cancer treated by intravesical BCG
por: Kashif Khan, Muhammad, et al.
Publicado: (2014)

Correlation of Male Overactive Bladder with Intravesical Prostatic Protrusion
por: Kim, Ki Hong, et al.
Publicado: (2010)

Disseminated BCG: Complications of Intravesical Bladder Cancer Treatment
por: To, Uyen, et al.
Publicado: (2014)

Intravesical therapy for bladder cancer in the pandemic of Covid-19
por: Teoh, Jeremy Y. C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_203qecp3va2v1ffroo2h2poe4a